Rhythm Biosciences (FRA:0RY) Common Stock: €23.47 Mil (As of Dec. 2025)


FRA:0RY Rhythm Biosciences Ltd FRA:0RY
31 GF Score
Price €0.06
! 5 Warning Signs
View Full Analysis

What is Rhythm Biosciences Common Stock?

Rhythm Biosciences FRA:0RY -3.48% 31 Common Stock is €23.47 Mil as of Dec. 2025. GuruFocus rates FRA:0RY with a GF Score™ of 31/100. The stock has 5 warning signs investors should review.

Rhythm Biosciences's quarterly common stock declined from Dec. 2024 (€22.82 Mil) to Jun. 2025 (€21.31 Mil) but then increased from Jun. 2025 (€21.31 Mil) to Dec. 2025 (€23.47 Mil).

Rhythm Biosciences's annual common stock increased from Jun. 2023 (€19.55 Mil) to Jun. 2024 (€21.25 Mil) and increased from Jun. 2024 (€21.25 Mil) to Jun. 2025 (€21.31 Mil).

Rhythm Biosciences Common Stock Historical Data

* Premium members only.

The historical data trend for Rhythm Biosciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhythm Biosciences Common Stock Chart

Rhythm Biosciences Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial 10.14 18.51 19.55 21.25 21.31

Rhythm Biosciences Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.53 21.25 22.82 21.31 23.47
FRA:0RY
31GF Score
Rhythm Biosciences Ltd FRA:0RY
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhythm Biosciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €23.47 Mil mean?
Rhythm Biosciences (FRA:0RY) has a Common Stock of €23.47 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Rhythm Biosciences and its competitors.
Is Rhythm Biosciences' Common Stock too high?
Rhythm Biosciences' current Common Stock is €23.47 Mil. Overall, Rhythm Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Rhythm Biosciences' Common Stock compare to TMO and DHR?
Rhythm Biosciences' Common Stock of €23.47 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Diagnostics & Research company?
A good Common Stock depends on the Medical Diagnostics & Research industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Rhythm Biosciences and its competitors. Rhythm Biosciences's current Common Stock is €23.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhythm Biosciences stock overvalued right now?
Rhythm Biosciences (FRA:0RY) has a current Common Stock of €23.47 Mil. The current Common Stock is €23.47 Mil. Rhythm Biosciences' overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Rhythm Biosciences (FRA:0RY), the current Common Stock is €23.47 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rhythm Biosciences Business Description

Other Exchanges RHY:Australia
Address 30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. The product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. The company operates predominantly in one business and geographical segment which is the research and development of biosciences in Australia.
31GF Score

Get the complete analysis for FRA:0RY

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price